FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2069883595> ?p ?o ?g. }

• W2069883595 endingPage "382" @default.
• W2069883595 startingPage "376" @default.
• W2069883595 abstract "Bleeding and thrombosis are major causes of morbidity and mortality in patients with chronic myeloproliferative disorders. We retrospectively evaluated 101 consecutive patients affected by primary thrombocytosis (46 male, 55 female, aged 18-84 years; mean +/- SD 61 +/- 15) followed for a period ranging from 6 months up to 10 years (median 5 years) at our hematological unit. At the time of diagnosis 48 patients were asymptomatic; 26 had clinical evidence of atherothrombosis (cerebral ischemic attacks, ischemic heart disease, peripheral occlusive arterial disease), ten had venous thrombosis, four experienced major hemorrhages, 23 presented microvascular ischemic manifestations namely erythromelalgia, paresthesias, acrocyanosis and dizziness. At presentation 51.2% of the patients had elevated serum lactic dehydrogenase, 34.5% hyperuricemia, and 23.4% serum creatinine > 1.2 mg/dL. Color Doppler ultrasound provided evidence of vascular stenosis or medium-intimal hyperplasia of epiaortic vessels in 48.9% of patients studied, and similar alterations of lower limb arteries in 23.8% of cases. Therapy modality included an antiplatelet agent (picotamide 300 mg/bid); a cytoreductive agent (busulphan, hydroxyurea, pipobroman or melphalan) was used when platelet count was > 800000/microL. Symptoms due to microvascular ischemia promptly regressed after picotamide and cytoreductive therapy. During follow-up. nine patients suffered from atherothrombotic events (transient ischemic attacks, ischemic stroke, unstable angina pectoris) and five developed deep vein thrombosis or superficial thrombophlebitis. Five patients experienced major hemorrhages (two melena, two hematuria, one perioperative bleeding); the two gastrointestinal hemorrhages occurred in patients self-medicated with non steroidal anti-inflammatory drugs, and the two episodes of hematuria occurred on oral anticoagulant therapy and aspirin respectively. No major bleeding occurred in patients on continuative therapy with picotamide, even in the presence of upper digestive tract disorders. Seven patients died: mortality resulted from one sudden coronary death, three solid neoplasia, one blast crisis, one anile, and one massive hemorrhage due to abdominal aortic prosthesis tearing. Our study suggests that a long-term antithrombotic prophylaxis with picotamide may be of benefit in patients affected by primary thrombocytosis; a controlled clinical trial is warranted to assess whether picotamide can ameliorate the natural history of the disease." @default.
• W2069883595 created "2016-06-24" @default.
• W2069883595 creator A5072921350 @default.
• W2069883595 creator A5074072927 @default.
• W2069883595 creator A5084121098 @default.
• W2069883595 creator A5089549661 @default.
• W2069883595 date "1996-01-01" @default.
• W2069883595 modified "2023-09-25" @default.
• W2069883595 title "Thrombotic and hemorrhagic complications in chronic myeloproliferative disorders" @default.
• W2069883595 cites W155690712 @default.
• W2069883595 cites W1570058278 @default.
• W2069883595 cites W1571376117 @default.
• W2069883595 cites W166660488 @default.
• W2069883595 cites W1964263010 @default.
• W2069883595 cites W1966406554 @default.
• W2069883595 cites W1969382756 @default.
• W2069883595 cites W1974615364 @default.
• W2069883595 cites W1986995565 @default.
• W2069883595 cites W1995607351 @default.
• W2069883595 cites W2003025436 @default.
• W2069883595 cites W2009955884 @default.
• W2069883595 cites W2038611905 @default.
• W2069883595 cites W2039687934 @default.
• W2069883595 cites W2039990435 @default.
• W2069883595 cites W2043045115 @default.
• W2069883595 cites W2043834061 @default.
• W2069883595 cites W2047192695 @default.
• W2069883595 cites W2047449101 @default.
• W2069883595 cites W2052905336 @default.
• W2069883595 cites W2058679293 @default.
• W2069883595 cites W2068741393 @default.
• W2069883595 cites W2072691059 @default.
• W2069883595 cites W2076914763 @default.
• W2069883595 cites W2077969468 @default.
• W2069883595 cites W2079873385 @default.
• W2069883595 cites W2095188600 @default.
• W2069883595 cites W2119315092 @default.
• W2069883595 cites W2139824837 @default.
• W2069883595 cites W2229971338 @default.
• W2069883595 cites W2320032845 @default.
• W2069883595 cites W2332302039 @default.
• W2069883595 cites W2335726355 @default.
• W2069883595 cites W2412060844 @default.
• W2069883595 cites W2461087637 @default.
• W2069883595 cites W249585176 @default.
• W2069883595 cites W305084277 @default.
• W2069883595 cites W4241803129 @default.
• W2069883595 cites W45813627 @default.
• W2069883595 doi "https://doi.org/10.1016/s0753-3322(96)89672-7" @default.
• W2069883595 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8952859" @default.
• W2069883595 hasPublicationYear "1996" @default.
• W2069883595 type Work @default.
• W2069883595 sameAs 2069883595 @default.
• W2069883595 citedByCount "19" @default.
• W2069883595 countsByYear W20698835952012 @default.
• W2069883595 countsByYear W20698835952013 @default.
• W2069883595 countsByYear W20698835952017 @default.
• W2069883595 countsByYear W20698835952020 @default.
• W2069883595 countsByYear W20698835952023 @default.
• W2069883595 crossrefType "journal-article" @default.
• W2069883595 hasAuthorship W2069883595A5072921350 @default.
• W2069883595 hasAuthorship W2069883595A5074072927 @default.
• W2069883595 hasAuthorship W2069883595A5084121098 @default.
• W2069883595 hasAuthorship W2069883595A5089549661 @default.
• W2069883595 hasConcept C126322002 @default.
• W2069883595 hasConcept C141071460 @default.
• W2069883595 hasConcept C2777424391 @default.
• W2069883595 hasConcept C2779788118 @default.
• W2069883595 hasConcept C2780868729 @default.
• W2069883595 hasConcept C71924100 @default.
• W2069883595 hasConcept C89560881 @default.
• W2069883595 hasConcept C90924648 @default.
• W2069883595 hasConceptScore W2069883595C126322002 @default.
• W2069883595 hasConceptScore W2069883595C141071460 @default.
• W2069883595 hasConceptScore W2069883595C2777424391 @default.
• W2069883595 hasConceptScore W2069883595C2779788118 @default.
• W2069883595 hasConceptScore W2069883595C2780868729 @default.
• W2069883595 hasConceptScore W2069883595C71924100 @default.
• W2069883595 hasConceptScore W2069883595C89560881 @default.
• W2069883595 hasConceptScore W2069883595C90924648 @default.
• W2069883595 hasIssue "8" @default.
• W2069883595 hasLocation W20698835951 @default.
• W2069883595 hasLocation W20698835952 @default.
• W2069883595 hasOpenAccess W2069883595 @default.
• W2069883595 hasPrimaryLocation W20698835951 @default.
• W2069883595 hasRelatedWork W1586374228 @default.
• W2069883595 hasRelatedWork W2003938723 @default.
• W2069883595 hasRelatedWork W2047967234 @default.
• W2069883595 hasRelatedWork W2118496982 @default.
• W2069883595 hasRelatedWork W2364998975 @default.
• W2069883595 hasRelatedWork W2369162477 @default.
• W2069883595 hasRelatedWork W2439875401 @default.
• W2069883595 hasRelatedWork W2492258041 @default.
• W2069883595 hasRelatedWork W4238867864 @default.
• W2069883595 hasRelatedWork W2525756941 @default.
• W2069883595 hasVolume "50" @default.
• W2069883595 isParatext "false" @default.
• W2069883595 isRetracted "false" @default.

• next